OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
27 hedge funds and large institutions have $689K invested in Orexigen Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
92% less capital invested
Capital invested by funds: $8.79M → $689K (-$8.1M)
Holders
27
Holding in Top 10
–
Calls
$4K
Puts
$27K
Top Buyers
| 1 | +$9.92K | |
| 2 | +$7.55K | |
| 3 | +$7.45K | |
| 4 |
Citigroup
New York
|
+$4.34K |
| 5 |
Millennium Management
New York
|
+$3K |
Top Sellers
| 1 | -$478K | |
| 2 | -$429K | |
| 3 | -$418K | |
| 4 |
BlackRock
New York
|
-$290K |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$213K |